Abstract
Fourteen novel pterostilbene (1) and \(3^\prime \)-methoxy pterostilbene (2) Mannich base derivatives (3–16) were synthesized via the microwave-assisted Mannich reaction of 1 or 2 with various secondary amines and formaldehyde. The regioselectivity of the reaction occurred preferentially at \(\hbox {C-3}^\prime (\hbox {and /or C-5}^\prime )\) position of the B-ring of stilbene. The biological testing results showed that all the target compounds exhibit antiproliferative activity against Hela cells from \(\hbox {IC}_{50}=22.5\)–\(65.3\,\upmu \hbox {M}\). Compounds 1–3, 7, 11–13, and 16 displayed higher (lower \(\hbox {IC}_{50}\) values) activity than the positive control cisplatin \((\hbox {IC}_{50}= 41.3\,\upmu \hbox {M})\).
Graphical Abstract
Similar content being viewed by others
Explore related subjects
Discover the latest articles, news and stories from top researchers in related subjects.Avoid common mistakes on your manuscript.
Introduction
Pterostilbene (trans-3,5-dimethoxy-\(4^\prime \)-hydroxystilbene, 1), a naturally occurring dimethylether analog of resveratrol, was first isolated from P. Santalinus (red sandalwood) and it is also found in several types of berries and grapes [1]. Pterostilbene has been shown to have a cancer chemopreventive effect similar to that of resveratrol and it is cytotoxic to a variety of tumor cell types, such as human gastric carcinoma cells [2], human prostate cancer cells [3], and lung cancer cells [4]. \(3^\prime \)-Methoxy pterostilbene (2), a naturally occurring homolog of pterostilbene, was isolated from Sphaerophysa salsula [5] and showed higher cytotoxic activities on some cancer cells than resveratrol [6].
Biological activity studies have shown that the development of structural analogs of antitumor agents possessing basic nitrogen atom moiety is of great value [7, 8]. Anticancer studies using several classes of polyaromatic antitumour agents indicate that the introduction of a nitrogen-containing side chain increases significantly the biological activity and potency of the parent compounds. For example, it has been shown that the presence of the nitrogen moiety in flavopiridol, a synthetic nitrogen-containing flavonoid with antitumor activity against various tumor cell lines, is critical for its antitumor effect [9]. The Mannich reaction is a commonly used way to introduce nitrogenous moieties, such as aminoalkyl group to phenols. The modification of an aminoalkyl side chain in aromatic substrates permits to increase significantly the biological potency of bioactive molecules due to the greater number of molecular sites for electrophilic attack by cellular constituents, as well as due to the cascade effect of preferential chemosensitization when compared with parent compounds [10]. Furthermore, Mannich bases have been associated with increased water solubility [11].
Resveratrol has been the subject of numerous investigations, and its cancer chemopreventive activity has been fully demonstrated [12]. Prompted by the close structural similarity of pterostilbene and resveratrol, as well as the current high interest in the development of a pterostilbene-based therapeutic [13, 14], we decided to synthesize two series of fourteen pterostilbene and \(3^\prime \)-methoxy pterostilbene Mannich base derivatives to be evaluated for their antiproliferative activity against human cervical carcinoma Hela cells by the standard CCK-8 assay.
Results and discussion
The synthetic route used for the construction of novel pterostilbene and \(3^\prime \)-methoxy pterostilbene Mannich base derivatives (3–16) is shown in Scheme 1. Pterostilbene (1) and \(3^\prime \)-methoxy pterostilbene (2) were synthesized by O-methylation, reduction, chlorination, Arbuzov rearrangement, and Wittig reaction using commercially available 3,5-dihydroxybenzoic acid, 4-hydroxybenzaldehyde, or vanillin as starting material as described previously by our group [15].
Our strategy for the synthesis of the C-aminomethylated derivatives relied upon the electrophilic substitution at \(\hbox {C-3}^\prime \) and/or \(\hbox {C-5}^\prime \) of the stilbene B-ring. This was achieved by the Mannich reaction of 1 and 2 with formaldehyde and secondary amines in methanol, introducing a dialkylaminomethyl group in the ortho- position of the phenolic group. The general conditions of the Mannich reaction for the phenol compounds are based on the substrate, the amine, and formaldehyde ratio in alcohol with prolonged heating. It was reported that microwave irradiation can be used for the Mannich reaction because of the considerable advantages over conventional heating, such as substantial rate enhancement cleaner reaction and improvement in yield [16, 17]. In our case, pterostilbene (1) or \(3^\prime \)-methoxypterostilbene (2), formaldehyde, and secondary amines in a 1:1.2:1.2 ratio, respectively, were stirred under microwave irradiation (600 W) for 0.5–2 h in methanol to afford the C-aminomethylated derivatives 3–16. The Mannich reaction of pterostilbene (1) with methylpiperazine would lead to a different product at different reaction times where the product was a mono-substituted product (compound 6, 0.5 h of reaction time) or a double-substituted product (compound 8, 2 h of reaction time).
The structures of all synthesized Mannich base were confirmed by \(^{1}\hbox {HNMR}, ^{13}\hbox {CNMR}\), and MS analysis. The \(^{1}\hbox {HNMR}\) spectra of compounds 3–9 clearly indicate the absence of the of \(\hbox {H-3}^\prime \) proton signal at \(\delta \,6.28\) (and \(\hbox {H-5}^\prime \) proton for compounds 8, 9) in the B-ring of pterostilbene (1). Similarly, the \(\hbox {H-5}^\prime \) proton at \(\delta \,6.91\) of \(3^\prime \)-methoxy pterostilbene (2) in the B-ring disappeared for compounds 10–16. The signal at \(\delta \) 3.60–4.10 indicated the presence of the aminomethyl group at \(\hbox {C-3}^\prime \,(\hbox {or C-5}^\prime )\) position of compounds 3–16.
The antiproliferative activity of the pterostilbene (1), \(3^\prime \)-methoxypterostilbene (2), and the Mannich base derivatives 3–16 was assessed using the CCK-8 [2H-tetrazolium, 5-(2,4-disulfophenyl)-3-(2-methoxy-4-nitrophenyl)-2-(4- nitrophenyl) inner salt, sodium salt (1:1)] assay using the human cervical carcinoma Hela cell line. The results are shown in Table 1. The dose-response curves for the CCK-8 assay of compounds 1, 2, 3 and 7 on Hela cells proliferation are shown in Fig. 1. Cisplatin (DDP) was used as positive control. The results show that all the test compounds exhibit moderate to potent antiproliferative activity against Hela cells.
In the series of pterostilbene Mannich bases, our data showed that compound 3, characterized by a dimethylaminomethyl group in the \(\hbox {C-3}^\prime \) position, was found to have an increase in antiproliferative activity \((\hbox {IC}_{50} = 23.3\,\upmu \hbox {M})\) when compared with parent compound pterostilbene \((\mathbf{1}, \hbox {IC}_{50} = 28.5\,\upmu \hbox {M})\). Compound 7 \((\hbox {IC}_{50} = 28.3\,\upmu \hbox {M})\), which contains a pyrrolidin-1-ylmethyl group substituent on the \(\hbox {C-3}^\prime \) position, presented with potency similar to that of parent compound pterostilbene (1). Compounds 1, 3, and 7 \((\hbox {IC}_{50}\) range 23.3–28.5 \(\upmu \hbox {M})\) showed more potent antiproliferative activity against Hela cells than the positive control cisplatin (DDP) \((\hbox {IC}_{50} = 41.3\, \upmu \hbox {M})\). In the series of \(3^\prime \)-methoxypterostilbene Mannich bases, although the introduction of a dialkylaminomethyl group did not increase the activity compared to its parent compound 2, compounds 11, 12, 13 and 16 exhibited some antiproliferative activity on Hela cells \((\hbox {IC}_{50}\) range of 35.4–38.7 \(\upmu \hbox {M})\) being slightly more potent than cisplatin (DDP) \((\hbox {IC}_{50}= 41.3\,\upmu \hbox {M})\).
The preliminary structure–activity relationship analysis revealed that pterotilbene (1) has a moderate antiproliferative activity on Hela cells. The introduction of smaller methoxy or dimethylaminomethyl side chains into the 3\(^\prime \)-position of 1 was to increase biological activity, and the introduction of larger dialkylaminomethyl side chain into 3\(^\prime \)-position of 1 was to decrease the activity. Based on these observations, the methoxy and dimethylaminomethyl groups were selected as suitable substituents at the 3\(^\prime \)-position of 1. The introduction of all dialkylaminomethyl side chain into 5\(^\prime \)-position of 3\(^\prime \)-methoxy pterostilbene (2) was to decrease the activity. As the antiproliferation assay was carried out in vitro, the inhibitory effect on Hela cell variance among these compounds could be attributed to the hydrophobicity and permeability changes resulting from different substituents and position of side chains in pterostilbene (1) .
Conclusion
In Summary, 14 new pterostilbene (1) and \(3^\prime \)-methoxy pterostilbene (2) Mannich base derivatives 3–16 were synthesized through a microwave-assisted Mannich reaction strategy. All the compounds were tested for their antiproliferative activity against Hela cells using the standard CCK-8 assay; the results indicating that compounds 1, 2, 3, 7, 11, 12, 13 and 16 were slightly more potent than anticancer drug cisplatin (DDP). The pterostilbene skeleton can serve as a promising structural template for the development of novel antiproliferative agents deserving further investigation.
Experimental
General information
Melting points were measured on an XRC-I apparatus and were uncorrected. Microwave reactions were performed using an XH-MC-1 microwave reactor (50–900 W) (Beijing Xianghu Science and Technology Development Co., China). \(^{1}\hbox {H}\) NMR and \(^{13}\hbox {C}\) NMR spectra were recorded on a Bruker AM-400 instrument, using tetramethylsilane as internal standard (s single; d doublet; t triplet; q quarlet; m multiplet), chemical shifts \((\delta )\) in ppm, and coupling constants (J) in Hz. Mass spectra were recorded using a VG Autospec-3000 and a ZA-BHS spectrometer (ESI or EI ionization method). Pterostilbene (1) and \(3^\prime \)-methoxy pterostilbene (2) were synthesized and purified according to our published procedure [15]. Formaldehyde, secondary amines, methanol, ethylacetate, petroleum ether, triethylamine, CCK-8 [2H-tetrazolium, 5-(2,4-disulfophenyl)-3-(2-methoxy-4-nitrophenyl)-2-(4-nitrophenyl) inner salt, sodium salt (1:1)] were obtained from Energy Chemicals. Column chromatography was carried out on silica gel (200–300 mesh). Commercially available AR grade or chemically pure reagents were used. Anhydrous solvents were dried and redistilled prior to their use.
General procedure for the synthesis of Mannich base derivatives 3–16
Compound 1 or 2 (200 mg, 0.78 mmol) was dissolved in methanol (10 mL), then formaldehyde (0.94 mmol) and a secondary amine (0.94 mmol) were introduced to this solution. The reaction mixture was stirred under microwave irradiation (600 W) at \(80\,^ {\circ }\hbox {C}\). The end of the reaction was determined by TLC. When the reaction was complete, the solvent was removed in vacuo. The residue was extracted with ethyl acetate \((3\times 20\,\hbox {mL})\) and water (15 mL). The organic phases were combined, washed with \(\hbox {H}_{2}\hbox {O}\), and dried over anhydrous sodium sulfate. The solvent was evaporated and resulting crude material was purified by silica gel column chromatography (ethyl acetate:petroleum ether:triethylamine, v / v, 1:9:0.01) to obtain desired products 3–16.
\((E){\text {-}}3^\prime \) -[(Dimethylamino)methyl]pterostilbene (3)
3 was obtained as yellow oil (169 mg, yield: 69 %). \(^{1}\hbox {H}\,\hbox {NMR }\,(\hbox {400 MHz}, \hbox {CDCl}_{3}){:} \delta \,9.83 (\hbox {s}, \hbox {1H}, \hbox {OH})\)7.23 \((\hbox {d}, \hbox {J} = 8.2\,\hbox {Hz}, \hbox {1H}, 6^\prime \hbox {-H}),\, 7.03 (\hbox {s}, \hbox {1H}, 2^\prime \hbox {-H}),\, 6.90 \,(\hbox {d}, \hbox {J} = 16.2\,\hbox {Hz}, \hbox {1H}, \beta \hbox {-CH=}), 6.76 (\hbox {d}, \hbox {J} \!=\! 16.2\,\hbox {Hz}, \hbox {1H}, \alpha \hbox {-CH=}), 6.73 (\hbox {d}, \hbox {J} = 8.6\,\hbox {Hz}, \hbox {1H}, 5^\prime \hbox {-H})., 6.54 (\hbox {s}, \hbox {2H}, \hbox {2-H and 6-H}), 6.27 \,(\hbox {s, 1H,4-}\hbox {H}), 3.71 (\hbox {s, 6H}, \hbox {3-OCH}_{3}\hbox { and }\hbox {5-OCH}_{3}), 3.55 (\hbox {s, 2H}, 3^\prime {-}\hbox {CH}_{2}\hbox {N}), 2.23 (\hbox {s, 6H}, \hbox {N}(\hbox {CH}_{3})_{2}); ^{13}\hbox {C NMR }(100\hbox { MHz}, \hbox {CDCl}_{3}): \delta 161.0,\! 158.3,\! 139.9,\! 129.0,\! 128.3,\! 127.3,\! 126.7,\! 125.8,\! 122.1, 116.4, 104.3, 99.4, 62.8, 55.3, 44.4; \hbox { ESIMS}\, m/z{:} 314\, [\hbox {M}+\hbox {H}]^{+}\).
\((E){\text {-}}3^\prime \) -[(Diethylamino)methyl]pterostilbene (4)
4 was obtained as yellow oil (168 mg, yield 63 %). \(^{1}\hbox {H NMR} \,(\hbox {400\,MHz, CDCl}_{3}){:}\;\delta \,7.22 \,(\hbox {d}, J = 8.3\hbox { Hz, 1H}, 6'\hbox {-H}),\, 7.03 \,(\hbox {s, 1H}, 2'\hbox {-H}),\, 6.90 \,(\hbox {d}, J = 16.2\hbox { Hz, 1H}, \beta \hbox {-CH}=),\, 6.76 \,(\hbox {d}, J = 16.2\hbox { Hz, 1H}, \alpha \hbox {-CH=}),\, 6.70 \,(\hbox {d}, J = 8.3\hbox { Hz, 1H}, 5'\hbox {-H}), 6.54 (\hbox {d, 2H, 2-H and 6-H}), 6.27 (\hbox {s, 1H,}\hbox {4-H}),\, 3.71 \,(\hbox {s, 6H, 3-OCH}_{3 }\hbox { and 5-OCH}_{3}),\, 3.68\, \,(\hbox {s, 2H}, 3^\prime \hbox {-CH}_{2}\hbox {N}), 2.53 (\hbox {q}, J = 6.8\hbox { Hz, 4H, 2CH}_{2}),\, 1.01 \,(\hbox {t}, J = 7.0\hbox { Hz, 6H,} \hbox {2CH}_{3}). ^{13}\hbox {C NMR }(\hbox {100 MHz, CDCl}_{3}): \delta 161.0, 158.6 140.0, 129.1, 128.2, 127.0, 126.7, 125.6, 122.3, 116.4, 104.3,\! 99.4, 56.9, 55.3, 46.3, 11.2;\hbox { ESIMS } m/z\, 342\hbox { [M+H]}^{+}\).
\((E){\text {-}}3^\prime \) -(Piperidin-1-ylmethyl)pterostilbene (5)
5 was obtained as white crystals (182 mg, yield 66 %), \(\hbox {m.p.}\;80{-}81\,^{\circ }\hbox {C}. ^{1}\hbox {H NMR }(400\hbox { MHz}, \hbox {CDCl}_{3}){:}\; \delta \,7.35 \,(\hbox {d}, J = 7.6\,\hbox { Hz}, 6^\prime \hbox {-H}),\, 7.15 \,(\hbox {s, 1H}, 2^\prime \hbox {-H}),\, 7.00 (\hbox {d}, J = 16.2\,\hbox { Hz,} \hbox {1H}, \beta \hbox {-CH=}),\, 6.86 \; (\hbox {d}, J = 16.2\,\hbox { Hz, 1H}, \alpha \hbox {-CH=}),\, 6.82 (\hbox {s,} \hbox {1H}, 5^\prime \hbox {-H}),\, 6.64 \,(\hbox {s,}\hbox {2H, 2-H and 6-H}),\, 6.37 \,(\hbox {d}, J = 2.1\,\hbox {Hz,} \hbox {1H, 4-H}),\, 3.83 \,(\hbox {s, 6H, 3-OCH}_{3} \hbox { and 5-OCH}_{3}),\, 3.73 \,(\hbox {s}, \hbox {2H}, 3^\prime \hbox {-CH}_{2}\hbox {N}),\, 2.57 \,(\hbox {t}, J \!=\! 2.3\,\hbox { Hz, 4H, NCH}_{2}),\, 1.69{-}1.65 (\hbox {m}, J \!=\! 5.0\,\hbox {Hz, 4H, 2CH}_{2}), 1.55{-}1.52 \,(\hbox {m, J = 1.6\,Hz,} \hbox {2H},\hbox {CH}_{2}); ^{13}\hbox {C NMR }(\hbox {100 MHz, CDCl}_{3}): \delta 159.9, 157.2,138.8, 128.0, 127.1, 126.0,\, 125.7,\, 124.6,\, 120.7, 115.3, 103.1, 98.3, 61.1, 54.3, 52.8, 24.8, 22.9; \hbox { ESIMS } m/z: \hbox { 354 [M+H]}^{+}\).
\((E){\text {-}}3^\prime \) -[(4-Methylpiperazin-1-yl)methyl]pterostilbene (6)
6 was obtained as yellow oil (184 mg, yield 64 %). \(^{ 1}\hbox {H NMR} \,(\hbox {400 MHz, CDCl}_{3}){:}\;\delta 7.26 \,(\hbox {d}, J \!=\! 8.3\,\hbox { Hz, 1H}, 6^\prime \hbox {-H}),\, 7.07 \,(\hbox {s, 1H}, 2^\prime \hbox {-H}), 6.91 (\hbox {d}, J \!=\! 16.2\,\hbox { Hz, 1H,}\,\beta \hbox {-CH=}),6.82 \,(\hbox {d}, J \!=\! 16.2\,\hbox { Hz, 1H}, \alpha \hbox {-CH=}), 6.74 (\hbox {d}, J \!=\! 7.9\,\hbox { Hz, 1H}, 5^\prime \hbox {-H}),\, 6.56 \,(\hbox {s, 2H, 2-H and 6-H}),\, 6.29 \,(\hbox {s, 1H,} \hbox {4-H}),\, 3.74 \,(\hbox {s,} \hbox {6H, 3-}\hbox {OCH}_{3}\hbox { and 5-OCH}_{3}), 3.66 \!(\hbox {s, 2H}, 3^\prime \hbox {-CH}_{2}\hbox {N}), 2.80\!-\! 2.27 (\hbox {m},~\hbox {8H, NCH}_{2}),\, 2.25 \,(\hbox {s, 3H, NCH}_{3});\,^{ 13}\hbox {C NMR } (\hbox {100 MHz}, \hbox {CDCl}_{3}): \delta 159.9, 156.7, 138.7, 127.8, 127.5,\, 126.3,\, 125.9, 124.9, 120.2, 115.4, 103.2, 98.4, 60.3, 54.3, 53.8, 51.3,\! 44.8; \hbox {ESIMS }m/z{:}\hbox { 369 [M+H]}^{+}\).
\((E){\text {-}}3^\prime \) -(Pyrrolidin-1-ylmethyl) pterostilbene (7)
7 was obtained as yellow oil (164 mg, yield 62 %). \(^{1}\hbox {H NMR} \,(\hbox {400 MHz, CDCl}_{3}){:} \delta \,9.53 \,(\hbox {s, 1H, OH}),\, 7.35 \,(\hbox {d}, J =\! 8.3, 1.8\,\hbox { Hz, 1H},6^\prime \hbox {-H}),\, 7.18 \,(\hbox {d}, J \!=\! 1.3\,\hbox { Hz, 1H}, 2^\prime \hbox {-H}),\, 7.02 \,(\hbox {d}, J = 16.2\hbox { Hz, 1H}, \beta \hbox {-CH=}),\, 6.89 \,(\hbox {d}, J = 16.2\hbox { Hz,} \hbox {1H}, \alpha \hbox {-CH=}),\, 6.85 \,(\hbox {d}, J =\hbox { 8.4Hz, 1H}, 5^\prime \hbox {-H}),\, 6.66 \,(\hbox {d}, J = 2.1\,\hbox { Hz, 2H, 2-H and 6-H}),\, 6.39 \,(\hbox {d}, J = 2.0\,\hbox { Hz, 1H, 4-H}),\, 3.87 \,(\hbox {d}, J = 6.3\,\hbox { Hz, 2H}, 3^\prime \hbox {-CH}_{2}\hbox {N}),\, 3.84 (\hbox {s, 6H, 3-OCH}_{3}\hbox { and 5-OCH}_{3}),\, 2.69 \,(\hbox {s, 4H, N}(\hbox {CH}_{2})_{2}),\, 1.88 \,(\hbox {s, 4H, 2CH}_{2}); ^{13}\hbox {C NMR }(\hbox {100 MHz, CDCl}_{3}){:} \delta \,160.8, 158.1, 139.8, 128.9, 128.1, 127.1, 126.3, 125.6, 122.3, 116.3, 104.1, 99.3, 58.5, 55.3, 53.4, 23.6; \hbox {ESIMS } m/z{:}\hbox { 340 [M+H]}^{+}\).
\((E){\text {-}}3^\prime ,5^\prime \) -Bis[(4-methylpiperazin-1-yl)methyl] pterostilbene (8)
8 was obtained as yellow oil (131 mg, yield 35 %). \(^{1}\hbox {H NMR} \,(\hbox {400 MHz, CDCl}_{3}){:} \delta \,7.18 \,(\hbox {s, 2H}, 2^\prime \hbox {-H and }6^\prime \hbox {-H}),\, 6.96 \,(\hbox {d}, J = 16.2\,\hbox { Hz, 1H}, \beta \hbox {-CH=}),\, 6.83 \,(\hbox {d}, J = 16.2\,\hbox { Hz,} \hbox {1H}, \alpha \hbox {-CH=}),\, 6.60 \,(\hbox {d}, J = 1.9\,\hbox { Hz, 2H, 2-H and 6-H}),\, 6.32 \,(\hbox {d}, J = 1.7 \hbox { Hz, 1H, 4-H}), 3.78 (\hbox {s, 6H, 3-OCH}_{3}\hbox { and}\hbox {5-}\hbox {OCH}_{3}),\, 3.62 (\hbox {d}, J \!=\! 4.3\hbox { Hz, 4H}, 3^\prime \hbox {-CH}_{2}\hbox {N and }5^\prime \hbox {-CH}_{2}\hbox {N}),\, 2.89{-}2.27 \,(\hbox {m, 16H, NCH}_{2}),\, 2.25 \,(\hbox {s, 6H, NCH}_{3});^{13}\hbox {C NMR }(\hbox {100} \hbox {MHz,}\,\hbox {CDCl}_{3}): \delta \, 160.8, 156.6, 139.8, 129.0, 127.7, 127.2, 125.7,\! 122.7,\! 104.1,\! 99.4,\! 58.8,\! 55.3,\! 54.9, 52.7, 45.9; \hbox {ESIMS} m/z{:}\, 481\hbox { [M+H]}^{+}\).
\((E){\text {-}}3^\prime ,5^\prime \) -Bis(morpholinomethyl)pterostilbene (9)
9 was obtained as yellow oil (117 mg, yield 33 %). \(^{1}\hbox {H NMR} \,(\hbox {400 MHz, CDCl}_{3}){:} \delta \,7.17 \,(\hbox {s, 2H}, 2^\prime \hbox {-H and }6^\prime \hbox {-H}),\, 6.92 \,(\hbox {d}, J = 16.2\,\hbox { Hz,} \hbox {1H}, \beta \hbox {-CH=}),\, 6.80 \,(\hbox {d}, J = 16.2\,\hbox { Hz}, \hbox {1H}, \alpha \hbox {-CH=}),\, 6.56 \,(\hbox {s, 2H, 2-H and 6-H}),\, 6.29 \,(\hbox {s, 1H, 4-H}), 3.74 \,(\hbox {s, 6H, 3-OCH}_{3}\hbox { and 5-OCH}_{3}), 3.67 (\hbox {s, 8H}, \hbox {OCH}_{2}), 3.58 (\hbox {s, 4H}, 3^\prime \hbox {-CH}_{2}\hbox {N \,and }\,5^\prime \hbox {-CH}_{2}\hbox {N}),\, 2.49 \,(\hbox {s, 8H},\, \hbox {NCH}_{2});\, ^{13}\hbox {C} \hbox { NMR }(\hbox {100 MHz, CDCl}_{3}):\delta 161.0, 156.2, 139.7, 128.8, 128.1, 127.7, 126.1,\, 122.3,\, 104.3,\, 99.5,\, 66.8,\, 59.3,\, 55.4, 53.2; \hbox {ESIMS }m/z{:}\, 455 \hbox { [M+H]}^{+}\).
\((E){\text {-}}3^\prime \) -Methoxyl-5 \(^\prime \) -((dimethylamino)methyl)pterostilbene (10)
10 was obtained as yellow oil (173 mg, yield 72 %). \(^{1}\hbox {H NMR }(\hbox {400 MHz, CDCl}_{3}){:}\;\delta \,8.63 \,(\hbox {s, 1H, OH}),\, 6.99 \,(\hbox {s,} \hbox {1H}, 6^\prime \hbox {-H}),\, 6.97 \,(\hbox {d}, J \!=\! 16.2\hbox { Hz, 1H}, \beta \hbox {-CH=}),\, 6.86 \,(\hbox {d}, J = 16.2 \hbox {Hz, 1H}, \alpha \hbox {-CH=}),\, 6.75 \,(\hbox {s, 1H}, 2^\prime \hbox {-H}),\, 6.64 \,(\hbox {d}, J = \hbox {2.1} \hbox {Hz, 2H, 2-H and 6-H}),\, 6.36 \,(\hbox {d}, J \!=\! \hbox {2.1 Hz, 1H, 4-H}),\, 3.93 \,(\hbox {s, 3H}, 3^\prime \hbox {-OCH}_{3}),\, 3.81 \,(\hbox {s, 6H, 3-OCH}_{3}\hbox { and 5-OCH}_{3}), 3.66\,(\hbox {s, 2H}, 5^\prime \hbox {-CH}_{2}\hbox {N}), 2.34 (\hbox {s, 6H, NCH}_{3});^{ 13}\hbox {C NMR }(\hbox {100} \hbox {MHz,} \hbox {CDCl}_{3}): \delta \,160.8, 148.0, 147.6, 139.6, 129.1, 127.9, 125.8, 121.9,\, 119.4,\, 108.7,\, 104.1,\, 99.4,\, 62.5,\, 55.8,\, 55.2,\, 44.4;\hbox {EIMS }m/z{:}\, 343\hbox { [M]}^{+}\).
\((E){\text {-}}3^\prime \) -Methoxyl-5 \(^\prime \) - ((diethylamino)methyl) pterostilbene (11)
11 was obtained as yellow oil (189 mg, yield 73 %). \(^{1}\hbox {H NMR }(\hbox {400 MHz, CDCl}_{3}): \delta \,6.90 \,(\hbox {s, 1H}, 6^\prime \hbox {-C}),\, 6.89 (\hbox {d}, J = 16.2\,\hbox { Hz}, \beta \hbox {-CH=}),\, 6.78 \,(\hbox {d, 1H}, J = \hbox {16.2 Hz},\alpha \hbox {-CH=}), 6.67 \,(\hbox {s, 1H}, 2^\prime \hbox {-H}),\, 6.56 (\hbox {d}, J = \hbox {2.1 Hz, 2H, 2-H}~\hbox {and 6-H}), 6.29 (\hbox {t}, J = \hbox {2.1 Hz, 1H,4-H}),\, 3.85 \,(\hbox {s, 3H}, 3^\prime ~\hbox {-OCH}_{3}),\, 3.74 (\hbox {s, 6H, 3-OCH}_{3}\hbox { and 5-OCH}_{3}),\, 3.71 \,(\hbox {s, 2H}, 5^\prime \hbox {-CH}_{2}\hbox {N}), 2.56 (\hbox {q}, J \!=\! \hbox {6.1 Hz, 4H, NCH}_{2}), 1.04 \,(\hbox {t}, J \!=\! \hbox {6.2 Hz, 6H, 2CH}_{3}); ^{ 13}\hbox {C NMR }(\hbox {100 MHz, CDCl}_{3})\!:\! \delta 160.8, 148.4, 147.9, 139.6, 129.4, 127.8, 125.8, 121.5, 119.6, 108.4, 104.1, 99.4, 56.0, 55.7, 55.2, 46.2, 11.0;\hbox { EIMS } m/z:371\hbox { [M]}^{+}\).
\((E){\text {-}}3^\prime \) -Methoxyl-5 \(^\prime \) -(piperidin-1-yl methyl) pterostilbene (12)
12 was obtained as yellow oil (185 mg, yield 69 %). \(^{1}\hbox {H NMR }(\hbox {400 MHz, CDCl}_{3}){:} \delta \,6.90 \,(\hbox {s, 1H}, 6^\prime \hbox {-H}),\, 6.89 \,(\hbox {d}, J = \hbox {16.2 Hz}, \beta \hbox {-CH=}),\, 6.77 \,(\hbox {d}, J \!=\! \hbox {16.2 Hz, 1H}, \alpha \hbox {-CH=}),\, 6.65 \,(\hbox {d}, J = \hbox {1.5 Hz, 1H}, 2^\prime \hbox {-H}),\, 6.56 \,(\hbox {d}, J = \hbox {2.2 Hz, 2H,} \hbox {2-H and 6-H}),\, 6.28 \,(\hbox {d}, J = \hbox {2.2 Hz, 1H, 4-H}),\, 3.84 \,(\hbox {s, 3H}, 3^\prime \hbox {-OCH}_{3}),\, 3.72 \,(\hbox {s, 6H, 3-OCH}_{3}\hbox { and 5-OCH}_{3}),\, 3.59 \,(\hbox {s, 2H}, 5^\prime \hbox {-CH}_{2}\hbox {N}),\, 2.60-2.26 \,(\hbox {m, 4H,} \hbox {NCH}_{2}),\, 1.59{-}1.52 \,(\hbox {m, 4H,} \hbox {CH}_{2}),\, 1.40 \,(\hbox {s, 2H, CH}_{2});\, ^{13}\hbox {C NMR }(\hbox {100 MHz}, \hbox {CDCl}_{3}): \delta \,160.8,\, 147.9,\, 147.6,\, 139.6,\, 129.6,\, 127.7,\, 125.6,\, 121.4, 119.4, 108.4, 104.0, 99.3, 61.8, 55.7, 55.4, 537, 25.7, 23.8; \hbox { EIMS }m/z{:}\, 383\hbox { [M]}^{+}\).
\((E){\text {-}}3^\prime \) -Methoxyl-5 \(^\prime \) -[(4-methylpiperazin-1-yl)methyl] pterostilbene (13)
13 was obtained as yellow oil (173 mg, yield 62 %). \(^{1}\hbox {H NMR }(\hbox {400 MHz, CDCl}_{3}){:}\delta \,6.99(\hbox {s, 1H}, 6^\prime \hbox {-H}),\, 6.98 \,(\hbox {d}, J = \hbox {16.2 Hz, 1H},\beta \hbox {-CH=}),\, 6.86 \,(\hbox {d}, J = \hbox {16.2 Hz, 1H}, \alpha \hbox {-CH=}),\, 6.78 \,(\hbox {d}, J = \hbox {1.4 Hz, 1H}, 2^\prime \hbox {-H}),\, 6.64 \,(\hbox {d}, J = \hbox {2.2 Hz, 2H, 2-H and 6-H}),\, 6.37 \,(\hbox {t}, J = \hbox {2.2 Hz, 1H, 4-H}),\, 3.94 \,(\hbox {s, 3H}, 3^\prime \hbox {-OCH}_{3}),\, 3.83 \,(\hbox {s, 6H, 3-OCH}_{3}\hbox { and 5-OCH}_{3}),\, 3.75 \,(\hbox {s, 2H}, 5^\prime \hbox {-CH}_{2}\hbox {N}),\, 2.88{-}2.35 \,(\hbox {m, 8H, NCH}_{2}),\, 2.32 \,(\hbox {s}, \hbox {3H, NCH}_{3});^{ 13}\hbox {C NMR} \,(\hbox {100 MHz, CDCl}_{3}): \delta \,160.9, 148.1, 147.2,\, 139.7,\, 129.1,\, 128.2,\, 126.1,\, 121.1,\, 119.6,\, 108.7, 104.4, 99.5, 61.0, 55.9, 55.3, 54.8, 52.3, 45.7;\hbox { EIMS } m/z: 398\hbox { [M]}^{+}\).
\((E){\text {-}}3^\prime \) -Methoxyl-5 \(^\prime \) -(pyrrolidin-1-ylmethyl) pterostilbene (14)
14 was obtained as yellow oil (173 mg, yield 67 %). \(^{1}\hbox {H NMR } \,(\hbox {400 MHz, CDCl}_{3}):\delta \,6.90 \,(\hbox {s, 1H}, 6^\prime \hbox {-H}),\, 6.89 (\hbox {d}, J = \hbox {16.2 Hz}, \beta \hbox {-CH=}),\, 6.78 \,(\hbox {d}, J = \hbox {16.2 Hz, 1H},\alpha \hbox {-CH=}),\, 6.68 \,(\hbox {s, 1H}, 2^\prime \hbox {-H}),\, 6.56\, (\hbox {d}, J = \hbox {2.1 Hz, 2H, 2-H}\, \hbox {and 6-H}),\, 6.29 \,(\hbox {s, 1H, 4-H}),\, 3.85 \,(\hbox {s, 3H}, 3^\prime \hbox {-OCH}_{3}),\, 3.77 \,(\hbox {s, 2H}, 5^\prime \hbox {-CH}_{2}\hbox {N}),\, 3.74 \,(\hbox {s, 6H, 3-OCH}_{3 }\hbox {and 5-OCH}_{3}), 2.66-2.49 \,(\hbox {m, 4H, NCH}_{2}),\, 1.79{-}1.74 \,(\hbox {m, 4H, CH}_{2}); ^{13} \hbox {C NMR }(\hbox {100}\hbox {MHz, CDCl}_{3}): \delta \,159.9,\, 147.1,\, 146.5,\, 138.7,\, 128.2, 127.1, 125.0, 120.4, 118.6, 107.7, 103.3, 98.5, 60.2, 55.0, 54.3, 49.1, 33.0;\hbox { EIMS } m/z{:}\hbox { 369[M]}^{+}\).
\((E){\text {-}}3^\prime \) -Methoxyl-5 \(^\prime \) -(morpholinomethyl)pterostilbene (15)
15 was obtained as yellow oil (199 mg, yield 74 %). \(^{1}\hbox {H NMR }(\hbox {400 MHz, CDCl}_{3}){:}\, \delta \,6.91(\hbox {s, 1H}, 6^\prime \hbox {-H}) 6.90 \,(\hbox {d}, J = \hbox {16.2 Hz, 1H}, \beta \hbox {-CH=}),\, 6.79 \,(\hbox {d}, J = 16.2\hbox { Hz, 1H}, \alpha \hbox {-CH=}),\, 6.69 \,(\hbox {s, 1H}, 2^\prime \hbox {-H}),\, 6.56 (\hbox {d}, J = \hbox {2.1 Hz, 2H, 2-H} \hbox {and 6-H}),\, 6.29 \,(\hbox {t}, J = \hbox {2.1 Hz, 1H, 4-H}),\, 3.85 \,(\hbox {s, 3H}, 3^\prime \hbox {-OCH}_{3}),\, 3.74 \,(\hbox {s, 6H, 3-OCH}_{3}\hbox { and 5-OCH}_{3}),\, 3.68 \,(\hbox {s, 2H}, 5^\prime \hbox {-CH}_{2}\hbox {N}),\, 3.67 \,(\hbox {t}, J = \hbox {4.2 Hz, 4H,} \hbox {NCH}_{2}),\, 2.52 \,(\hbox {s, 4H,} \hbox {OCH}_{2}).^{ 13}\hbox {C NMR }\,(\hbox {100 MHz, CDCl}_{3})\,{:}\, \delta \,160.9, 148.0, 146.9, 139.5, 129.0, 128.4, 126.1, 120.7, 119.7, 108.8, 104.2, 99.5, 66.7, 61.5, 55.8, 55.1, 52.8;\hbox { EIMS }m/z: \hbox { 385 [M]}^{+}\).
\((E){\text {-}}3^\prime \) -Methoxyl-5 \(^\prime \) -(piperidin-4-ol-1-ylmethyl)pterostilbene (16)
16 was obtained as yellow oil (170 mg, yield 61 %). \(^{1}\hbox {H NMR } \,(\hbox {400 MHz, CDCl}_{3}){:} \delta \,6.98 (\hbox {d}, J \!=\! 16.2,\hbox { Hz,} \hbox {1H}, \beta \hbox {-CH=}),\, 6.97(\hbox {s, 1H}, 6^\prime \hbox {-H}),\, 6.86 \,(\hbox {d}, J = \hbox {16.2 Hz, 1H}, \alpha \hbox {-CH=}),\, 6.75 \,(\hbox {d}, J = \hbox {1.2 Hz, 1H}, 2^\prime \hbox {-H}),\, 6.64 \,(\hbox {d}, J = \hbox {2.2 Hz, 2H, 2-H and 6-H}),\, 6.37 \,(\hbox {t}, J = \hbox {2.1 Hz, 1H,4-H}),\, 3.93 \,(\hbox {s, 3H}, 3^\prime \hbox {-OCH}_{3}),\, 3.82 \,(\hbox {s, 6H, 3-OCH}_{3}\hbox { and 5-OCH}_{3}),\, 3.72 \,(\hbox {s, 2H}, 5^\prime \hbox {-CH}_{2}\hbox {N}),\, 3.68{-}3.65(\hbox {m, 1H, CH-O}),\, 2.86{-}2.37 \,(\hbox {m, 4H, NCH}_{2}),\, 1.93{-}1.60 \,(\hbox {m, 4H, 2CH}_{2}); ^{13} \hbox {C NMR }(\hbox {100 MHz, CDCl}_{3}): \delta \,160.8,\, 147.9,\, 147.4,\, 139.6,\, 129.4, 127.9, 125.8, 122.0, 119.2, 108.3,\, 104.1,\, 99.4,\, 58.0,\, 55.8, 55.2, 53.3, 29.8, 23.5;\hbox { EIMS }m/z: 399\hbox {[M]}^{+}\).
Assay for antiproliferative activity
The CCK-8 reagent solution \((10\,\%, 10\,\upmu \hbox {L})\) was added to each well of a 96-well microtiter plate containing \(5\times 10^{3}\) cells (Hela), then different concentrations of compounds 1–16 \((100, 25, 6.25, 1.56, 0.39, 0.0976, 0.0244, 0.0061\,\upmu \hbox {M})\) were added and incubated for 48 h [18]. Absorbance was measured at \(450\sim 490\) nm using a microplate reader. A dose-response curve was plotted for each compound, and the half maximal inhibitory concentration \((\hbox {IC}_{50})\) for cancer cell lines was recorded.
References
Rimando AM, Cuendet M, Desmarchelier C, Mehta RG, Pezzuto JM, Duke SO (2002) Cancer chemopreventive and antioxidant activities of pterostilbene, a naturally occurring analogue of resveratrol. J Agric Food Chem 50:3453–3457. doi:10.1021/jf0116855
Pan MH, Chang YH, Badmaev V, Nagabhushanam K, Ho CT (2007) Pterostilbene induces apoptosis and cell cycle arrest in Human gastric carcinoma cells. J Agric Food Chem 55:7777–7785. doi:10.1021/jf071520h
Ko HS, Kim JS, Cho SM, Cho SM, Lee HJ, Ahn KS, Kim SH, Lee EO (2014) Urokinase-type plasminogen activator expression and Rac1/WAVE-2/Arp2/3 pathway are blocked by pterostilbene to suppress cell migration and invasion in MDA-MB-231 cells. Bioorg Med Chem Lett 24:1176–1179. doi:10.1016/j.bmcl.2013.12.115
Chen RJ, Tsai SJ, Ho CT, Pan MH, Ho YS, Wu CH, Wang YJ (2012) Chemopreventive effects of pterostilbene on urethane-induced lung carcinogenesis in mice via the inhibition of EGFR-mediated pathways and the induction of apoptosis and autophagy. J Agric Food Chem 60:11533–11541. doi:10.1021/jf302778a
Gill MT, Bajaj R, Chang CJ, Nichols DE, Mclaughlin JL (1987) 3,3\(^\prime \),5\(^\prime \)-Tri-\(O\)-methylpiceatanol and 4,3\(^\prime \),5\(^\prime \)-tri-\(O\)-methylpiceatannol: improvements over piceatannol in bioactivity. J Nat Prod 50:36–40. doi:10.1021/np50049a006
Singh SK, Ruchelman AL, Li TK, Li TK, Liu A, Liu LF, LaVoie EJ (2003) Nitro and amino substitution in the D-ring of 5-(2-dimethyla-minoethyl)- 2,3-methylenedioxy-5H-dibenzo-[c, h][1,6]naphthyridin-6-ones: effect on topoisomerase-I targeting activity and cytotoxicity. J Med Chem 46:2254–2257. doi:10.1021/jm020498a
Zhu S, Ruchelman AL, Zhou N, Liu A, Liu LF, Lavioe EJ (2006) 6-Substituted 6H-dibenzo[c,h][2,6]naphthyridin-5-ones: reversed lactam analogues of ARC-111 with potent topoisomerase I-targeting activity and cytotoxicity. Bioorg Med Chem 14:3131–3143. doi:10.1016/j.bmc.2005.12.028
Liu T, Xu Z, He Q, Chen Y, Yang B, Hu Y (2007) Nitrogen-containing flavonoids as CDK1/Cyclin B inhibitors: design, synthesis, and biological evaluation. Bioorg Med Chem Lett 17:278–281. doi:10.1016/j.bmcl.2006.07.088
Tonelli M, Tasso B, Mina L, Paglietti G, Boido V, Sparatore F (2013) Primary antiproliferative activity evaluationof 1-(quinolizidin-1\(^\prime \)-yl)methyland1-(\(\omega \)-tert-amino)alkyl-substituted 2-phenyl-,2-benzyl- and 2-[(benzotriazol-1/2-yl)methyl]benzimidazoleson huma ncancer cell lines. Mol Divers 17:409–419. doi:10.1007/s11030-013-9440-3
Liu HR, Huang XQ, Lou DH, Liu X, Liu WK, Wang QA (2014) Synthesis and acet-ylc-holinesterase inhibitory activity of Mannich base derivatives flavokawain B. Bioorg Med Chem Lett 24:4749–4753. doi:10.1016/j.bmcl.2014.07.087
Joshi D, Field J, Murphy J, Abdelrahim M, Schönherr H, Sparrow JR, Ellestad G, Nakanishi K, Zask A (2013) Synthesis of antioxidants for prevention of age-related macular degeneration. J Nat Prod 76:450–454. doi:10.1021/np300769c
Lu C, Guo Y, Li J, Yao M, Liao Q, Xie Z, Li X (2012) Design, synthesis, and evaluation of resveratrol derivatives as Aß\(_{1-42}\) aggregation inhibitors, antioxidants, and neuroprotective agents. Bioorg Med Chem Lett 22:7683–7687. doi:10.1016/j.bmcl.2012.09.105
Paul S, Rimando AM, Lee HJ, Lee HJ, Ji Y, Reddy BS, Suh N (2009) Anti-inflammatory action of pterostilbene is mediated through the p38 mitogen-activated protein kinase pathway in colon cancer cells. Cancer Prev Res 2:650–657. doi:10.1158/1940-6207.CAPR-08-0224
Mizuno CS, Ma G, Khan S, Patny A, Avery MA, Rimando AM (2008) Design, synthesis, biological evaluation and docking studies of pterostilbene analogs inside PPAR\(\alpha \). Bioorg Med Chem 16:3800–3808. doi:10.1016/j.bmc.2008.01.051
Wang GQ, Chen YL, Han MS, Sun L, Wang QA (2011) Synthesis and biological activity of pterostilbene and 3-methoxy pterostilbene and their glucosides derivatives. Chin J Org Chem 31:2114–2120
Bhupesh SS, Nyaradzai N (2012) A novel microwave synthesis of quinoline-3-carboxylic acid derivatives for treatment against human African trypanosomiasis. Mol Divers 16:685–695. doi:10.1007/s11030-012-9401-2
Peng YQ, Dou RL, Song GH (2005) Dramatically accelerated synthesis of \(\beta \)-aminoketones via aqueous mannich reaction under combined microwave and ultrasound irradiation. Synlett 14:2245–2247
Hideyuki T, Munetaka I, Fumio O, Kazumi S, Tomoyuki H, Keiji S, Masami W (1999) A water-soluble tetrazolium salt useful for colorimetric cell viability assay. Anal Commun 36:47–50. doi:10.1039/A809656B
Acknowledgments
We thank the National Natural Science Foundation of China (No. J1210040) and the Hunan Provincial Natural Science Foundation of China (No. 14JJ2048) for financial support.
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
About this article
Cite this article
Liu, C., Dong, L., Wang, S. et al. Synthesis and antiproliferative activity of pterostilbene and \(3^\prime \)-methoxy pterostilbene Mannich base derivatives against Hela cells. Mol Divers 19, 737–743 (2015). https://doi.org/10.1007/s11030-015-9615-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11030-015-9615-1